Showing 28,961 - 28,980 results of 29,377 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (teer decrease)) ))', query time: 1.08s Refine Results
  1. 28961

    Annual red bone marrow dose by age and calendar year for the three birth cohorts for A) Men, B) Women) based on the multivariate regression model (Table 3). by Wolfgang Hoffmann (30039)

    Published 2013
    “…Adjacent lines depict annual doses of the same birth cohorts for later calendar years in five year steps. This allows a comparison between the impact of increasing age and secular trend over calendar years. …”
  2. 28962

    Pathway analysis for alanine and beta-alanine metabolism. by Jie Meng (152665)

    Published 2013
    “…<p>The map displays selected steps from KEGG pathways map00473, ‘D-Alanine metabolism’, and map00410, ‘beta-Alanine metabolism’. …”
  3. 28963

    Investigation of Spontaneous Transition from Low-Molecular-Weight Hydrogel into Macroscopic Crystals by Yujiang Wang (615885)

    Published 2008
    “…The results indicated that the transition process progressed in two steps: (1) after forming the initial crystals, the surrounding gelator molecules assembled gradually to them, and (2) as the gelator concentration decreased, the aggregating fibers dissociated gradually into solution, therefore making more molecules assemble to the crystals.…”
  4. 28964

    Table 4_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  5. 28965

    Supplementary file 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  6. 28966

    Table 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  7. 28967

    Table 1_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  8. 28968

    USUV replicates in STAT1-sufficient peripheral tissues leading to spleen and liver pathology. by Amy N. Nelson (21763146)

    Published 2025
    “…<b>(H)</b> Immunostaining of liver tissue harvested from a <i>Stat1</i><sup>-/-</sup> mouse using the histiocyte marker CD68, anti-JEV NS3 to mark USUV infection, and DAPI with a 50 µm scale bar. …”
  9. 28969

    Table 3_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  10. 28970

    Determination of whole genome attractors for atRA and DMSO responses. by Masa Tsuchiya (78226)

    Published 2010
    “…<p>Temporal probability distributions of (A) <i>r<sub>v</sub></i> and (B) <i>I</i> for atRA (upper panel) and DMSO (lower panel) for <i>n</i> = 10, 50, 200 genes randomly selected from whole genome. …”
  11. 28971

    Quantitative changes in <i>Clostridium thermocellum</i> cellulosome composition in response to carbon substrate – Part II. by Babu Raman (264806)

    Published 2009
    “…Structural, catalytic and/or binding module information was obtained from the following sources: <a href="http://pfam.sanger.ac.uk/" target="_blank">http://pfam.sanger.ac.uk/</a>; <a href="http://www.cazy.org/" target="_blank">http://www.cazy.org/</a>; <a href="http://genome.ornl.gov/microbial/cthe/" target="_blank">http://genome.ornl.gov/microbial/cthe/</a>. …”
  12. 28972

    Table 7_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period-cohort analy... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  13. 28973

    Supplementary file 2_Global, regional, and national temporal trends in prevalence, deaths and disability-adjusted life years for chronic pulmonary disease, 1990–2021: an age-period... by Wubing Cao (20821589)

    Published 2025
    “…However, age-standardized deaths and DALYs significantly decreased across all five SDI regions. From an age effect perspective, globally, over 50% of COPD prevalence is concentrated among individuals aged 65 years and older, particularly in middle, low-middle, and high-middle SDI regions. …”
  14. 28974

    Optimization of sample collection, extraction and ELISA protocols to measure cortisol level in zebrafish larvae. by Chen-Min Yeh (225051)

    Published 2013
    “…(<b>E</b>) An incubation of HRP with TMB at a pH level of 4.5 gives the highest signal intensity, whereas signal detection decreases sharply at pH levels lower and higher than 3.5 and 6, respectively. …”
  15. 28975

    DataSheet1_Identification of immune-related biomarkers for intracerebral hemorrhage diagnosis based on RNA sequencing and machine learning.docx by Congxia Bai (11728634)

    Published 2024
    “…Background<p>Intracerebral hemorrhage (ICH) is a severe stroke subtype with high morbidity, disability, and mortality rates. …”
  16. 28976

    DataSheet1_Curcumin Ameliorates Cardiac Fibrosis by Regulating Macrophage-Fibroblast Crosstalk via IL18-P-SMAD2/3 Signaling Pathway Inhibition.DOCX by Jing Zhao (21160)

    Published 2022
    “…<p>Ethnopharmacological relevance: Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. …”
  17. 28977

    Table_2_“Longitudinal Fecal Microbiome Study of Total Body Irradiated Mice Treated With Radiation Mitigators Identifies Bacterial Associations With Survival”.xlsx by Kelvin Li (158276)

    Published 2021
    “…Survival improved relative to control (30.0%) for G-CSF (80%, p-value = 0.025), G-CSF/JP4-039 (70%, p-value = 0.084), but not for JP4-039 (50.0%). In the second experiment, mice were administered mitigation drugs “inhibiting programmed cell death” pathways: JP4-039 (anti-apoptosis), necrostatin-1 (anti-necroptosis), and baicalein (anti-ferroptosis), in eight combinations. …”
  18. 28978

    FIGURE 3 from Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers by Taraswi Mitra Ghosh (16616796)

    Published 2023
    “…<b>B,</b> Apoptosis (caspase 3/7 assay): Levels of caspase 3/7 enzyme (a marker of apoptosis) activities measured followed CONV-TOPO, CONV-DTX, METRO-TOPO, and the combination of CONV-DTX + METRO-TOPO 72 hours treatment. …”
  19. 28979

    Table_3_“Longitudinal Fecal Microbiome Study of Total Body Irradiated Mice Treated With Radiation Mitigators Identifies Bacterial Associations With Survival”.xlsx by Kelvin Li (158276)

    Published 2021
    “…Survival improved relative to control (30.0%) for G-CSF (80%, p-value = 0.025), G-CSF/JP4-039 (70%, p-value = 0.084), but not for JP4-039 (50.0%). In the second experiment, mice were administered mitigation drugs “inhibiting programmed cell death” pathways: JP4-039 (anti-apoptosis), necrostatin-1 (anti-necroptosis), and baicalein (anti-ferroptosis), in eight combinations. …”
  20. 28980

    DataSheet1_Selective Photocatalytic Oxidation of Glycerol and 3-Pyridinemethanol by Nanotube/Nanowire-Structured TiO2 Powders Obtained by Breakdown Anodization.docx by Sıdıka Çetinkaya (12536077)

    Published 2022
    “…<p>Nanotube/nanowire-structured TiO<sub>2</sub> was formed on the Ti surface by an anodic oxidation method performed at different potential values (50 or 60 V) and for different times (3 or 5 h). …”